Semaglutide vs Tirzepatide: Doses of Tirzepatide and Semaglutide While Semaglutide and Tirzepatide belong to classes of drugs known as GLP-1 receptor agonists and share the common goal of aiding weight loss, notable distinctions between the two medications warrant consideration
End-stage liver disease (cirrhosis) 4
Additionally, if you have a pituitary tumor or other brain lesion causing your hormone problems, sermorelin may not be appropriate
These include: Acute gallbladder disease (added to warning label in March 2022) Acute problems Acute pancreatitis Diabetic retinopathy complications in patients with type 2 Diabetes Gastrointestinal obstruction Ileus (added to the warning label in September 2023) Heart rate increase Hypoglycemia Possible thyroid tumors, including cancer Severe allergic reactions and hypersensitivity reactions, including anaphylaxis and angioedema Suicidal thoughts or behavior If you are taking Wegovy or any other GLP-1 drug like Mounjaro or Rybelsus , contact your doctor if you experience new or worsening side effects
Phase 3: mid titration (weeks 9 through 12) Semaglutide dose: 1.0 mg per week This dose represents a significant efficacy threshold
Recently, Medicare announced that health plans operating in the Medicare D (outpatient) program could provide limited access to Wegovy for patients who are overweight or obese and have preexisting heart disease